Drug Company Magic, Part 2
As we move further into 2017, I am increasingly concerned about the impact drug price increases have on your premiums. I’ve written before about the “magical” way drug companies arrive at their pricing.
Blue Cross considers it an important part of our mission to improve the health and lives and Louisianians. We want to give our family, friends and neighbors financial security in their day-to-day lives against terrible illnesses, give them a clear path to improving their health and help them put off chronic disease for as long as possible. A better quality of life for everyone is our goal, and we’re currently doing that as a participant in healthcare.gov.
Mike Bertaut appears on the Jim Engster Show to rehash the demise of the AHCA and to discuss what could be coming next out of our nation’s capital.
Fair enough!
Straight Talk would normally come to you today, but instead we are eagerly watching the latest developments out of Washington, D.C., on the American Health Care Act.
In case you missed it, congressional Republicans are fast-tracking through normal procedures a couple of draft bills that could have huge impacts on the Affordable Care Act. Though not as ambitious as the original ACA, which was more than 2,800 pages long, the American Health Care Act (which the two draft bills together make up, btw) would change a lot in a relatively brief 122 pages.
